Cargando…

Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review

Background: Postviral olfactory dysfunction (PVOD) is a clinical challenge due to limited therapeutic options and poor prognosis. Both steroids and olfactory training have been proved to be effective for olfactory dysfunction with varied etiologies. We sought to perform a systematic review to summar...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Fan, Huang, Tianhao, Wei, Yongxiang, Wu, Dawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387929/
https://www.ncbi.nlm.nih.gov/pubmed/34456675
http://dx.doi.org/10.3389/fnins.2021.708510
_version_ 1783742545972428800
author Yuan, Fan
Huang, Tianhao
Wei, Yongxiang
Wu, Dawei
author_facet Yuan, Fan
Huang, Tianhao
Wei, Yongxiang
Wu, Dawei
author_sort Yuan, Fan
collection PubMed
description Background: Postviral olfactory dysfunction (PVOD) is a clinical challenge due to limited therapeutic options and poor prognosis. Both steroids and olfactory training have been proved to be effective for olfactory dysfunction with varied etiologies. We sought to perform a systematic review to summarize the evidence of steroids or olfactory training for patients with PVOD. Methods: A systematic literature review using PubMed, Embase, Cochrane Library, and Web of Science was conducted to identify studies assessing olfactory change in patients with PVOD receiving steroid or olfactory training. Results: Of the initial 273 abstracts reviewed, 20 articles with data from 2,415 patients with PVOD were included. Treatments including topical steroids, systemic steroids, classical olfactory training (COT), modified olfactory training (MOT), and olfactory training with steroid were analyzed. Both psychophysical olfactory testing and subjective symptom scores were utilized to assess the olfactory function. The routine use of nasal steroid spray alone during the management of PVOD seems to have no positive effect on olfactory dysfunction. Direct injection of steroid or nasal steroid spray into the olfactory cleft significantly improved the olfactory function in patients with PVOD. Olfactory improvement is greater than that of the natural course of the disease with short-term COT. Patients with PVOD would benefit more from long-term COT (>12 weeks). Treatment duration, various odorants, olfactory training devices, changing the types of odors periodically, different molecular odorants, and different concentrations of odorants tended to increase the efficiency of MOT. Clinically significant improvement after olfactory training was defined as an increase of threshold, discrimination, and identification (TDI) score ≥6. From week 24 to week 36, both COT and MOT groups reached the maximum therapeutic effect regarding the number of participants achieving clinically significant improvement. A combination of local or oral steroids with olfactory training is more efficient than COT only. Conclusion: Olfactory function in patients with PVOD was effectively improved through direct steroid administration in the olfactory cleft, COT, or modification of COT. The addition of topical steroids to COT therapy showed a tendency for greater olfactory improvement in patients with PVOD.
format Online
Article
Text
id pubmed-8387929
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83879292021-08-27 Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review Yuan, Fan Huang, Tianhao Wei, Yongxiang Wu, Dawei Front Neurosci Neuroscience Background: Postviral olfactory dysfunction (PVOD) is a clinical challenge due to limited therapeutic options and poor prognosis. Both steroids and olfactory training have been proved to be effective for olfactory dysfunction with varied etiologies. We sought to perform a systematic review to summarize the evidence of steroids or olfactory training for patients with PVOD. Methods: A systematic literature review using PubMed, Embase, Cochrane Library, and Web of Science was conducted to identify studies assessing olfactory change in patients with PVOD receiving steroid or olfactory training. Results: Of the initial 273 abstracts reviewed, 20 articles with data from 2,415 patients with PVOD were included. Treatments including topical steroids, systemic steroids, classical olfactory training (COT), modified olfactory training (MOT), and olfactory training with steroid were analyzed. Both psychophysical olfactory testing and subjective symptom scores were utilized to assess the olfactory function. The routine use of nasal steroid spray alone during the management of PVOD seems to have no positive effect on olfactory dysfunction. Direct injection of steroid or nasal steroid spray into the olfactory cleft significantly improved the olfactory function in patients with PVOD. Olfactory improvement is greater than that of the natural course of the disease with short-term COT. Patients with PVOD would benefit more from long-term COT (>12 weeks). Treatment duration, various odorants, olfactory training devices, changing the types of odors periodically, different molecular odorants, and different concentrations of odorants tended to increase the efficiency of MOT. Clinically significant improvement after olfactory training was defined as an increase of threshold, discrimination, and identification (TDI) score ≥6. From week 24 to week 36, both COT and MOT groups reached the maximum therapeutic effect regarding the number of participants achieving clinically significant improvement. A combination of local or oral steroids with olfactory training is more efficient than COT only. Conclusion: Olfactory function in patients with PVOD was effectively improved through direct steroid administration in the olfactory cleft, COT, or modification of COT. The addition of topical steroids to COT therapy showed a tendency for greater olfactory improvement in patients with PVOD. Frontiers Media S.A. 2021-08-12 /pmc/articles/PMC8387929/ /pubmed/34456675 http://dx.doi.org/10.3389/fnins.2021.708510 Text en Copyright © 2021 Yuan, Huang, Wei and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Yuan, Fan
Huang, Tianhao
Wei, Yongxiang
Wu, Dawei
Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review
title Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review
title_full Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review
title_fullStr Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review
title_full_unstemmed Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review
title_short Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review
title_sort steroids and olfactory training for postviral olfactory dysfunction: a systematic review
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387929/
https://www.ncbi.nlm.nih.gov/pubmed/34456675
http://dx.doi.org/10.3389/fnins.2021.708510
work_keys_str_mv AT yuanfan steroidsandolfactorytrainingforpostviralolfactorydysfunctionasystematicreview
AT huangtianhao steroidsandolfactorytrainingforpostviralolfactorydysfunctionasystematicreview
AT weiyongxiang steroidsandolfactorytrainingforpostviralolfactorydysfunctionasystematicreview
AT wudawei steroidsandolfactorytrainingforpostviralolfactorydysfunctionasystematicreview